Suddenly, the agreement between Bristol and Celgene seems fragile. And after?


WWhat will happen to Celgene (CELG) if the proposed $ 74 billion acquisition by Bristol-Myers Squibb (BMY) dies?

"It would be a total nightmare, a pessimistic scenario for Celgene.The members of his board of directors are currently doing everything in their power to prevent any transaction activist hedge fund.

Unlock this item by subscribing to STAT Plus and enjoy your first 30 days for free!


Source link